April 26, 2022
Video
Before closing out her discussion on novel therapy for EGFR exon 20–positive NSCLC, Zofia Piotrowska, MD, shares her hopes for future developments in care.
April 26, 2022
Video
Practical advice regarding the selection and management of amivantamab or mobocertinib in patients diagnosed with EGFR exon 20–positive NSCLC.
April 26, 2022
Video
Comprehensive insight on the two novel, targeted agents approved for the management of EGFR exon 20–positive NSCLC following frontline therapy.
April 26, 2022
Video
Expert oncologist Zofia Piotrowska, MD, reviews the case of a patient managed with frontline chemotherapy after receiving a diagnosis of stage 4 NSCLC.
March 14, 2020
Video
Zofia Piotrowska, MD, MHS, discusses the rationale for conducting the FLAURA trial in patients with EGFR-mutant non–small cell lung cancer and how the use of osimertinib impacted the treatment landscape for this patient population.
February 17, 2020
Video
Zofia Piotrowska, MD, MHS, discusses the data from the randomized phase III FLAURA trial, which led to the widespread use of frontline osimertinib for the treatment of EGFR-mutant lung cancers.